Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Krittanon Kongtragulsub
Institution:
Prince of Songkla University
Observed institution:
Prince of Songkla University
ORCID:
0000-0002-6654-9448
Observed ORCID:
0000-0002-6654-9448
OpenAlex ID:
A5065571477
Factors Associated with Anxiety and Depression Among Micro, Small, and Medium Enterprise Restaurant Entrepreneurs Due to Thailand’s COVID-19-Related Restrictions: A Cross-Sectional Study
2022
·
Phoomjai Sornsenee
, Krittanon Kongtragulsub
, et al.
·
Risk Management and Healthcare Policy
·
12
PDF
The Phase Ib IMPACT Trial of Intramuscular Personalized Neoantigen Synthetic Long Peptide Vaccines in Patients with Advanced Melanoma and Renal Cell Carcinoma
2026
·
Nussara Pakvisal
, Piriya Wongkongkathep
, et al.
·
Clinical Cancer Research
·
2
PDF
Supplementary Data 5 from The Phase Ib IMPACT Trial of Intramuscular Personalized Neoantigen Synthetic Long Peptide Vaccines in Patients with Advanced Melanoma and Renal Cell Carcinoma
2026
·
Nussara Pakvisal
, Piriya Wongkongkathep
, et al.
Data from The Phase Ib IMPACT Trial of Intramuscular Personalized Neoantigen Synthetic Long Peptide Vaccines in Patients with Advanced Melanoma and Renal Cell Carcinoma
2026
·
Nussara Pakvisal
, Piriya Wongkongkathep
, et al.
Supplementary Figures and Tables from The Phase Ib IMPACT Trial of Intramuscular Personalized Neoantigen Synthetic Long Peptide Vaccines in Patients with Advanced Melanoma and Renal Cell Carcinoma
2026
·
Nussara Pakvisal
, Piriya Wongkongkathep
, et al.
Supplementary Data 2 from The Phase Ib IMPACT Trial of Intramuscular Personalized Neoantigen Synthetic Long Peptide Vaccines in Patients with Advanced Melanoma and Renal Cell Carcinoma
2026
·
Nussara Pakvisal
, Piriya Wongkongkathep
, et al.
Supplementary Data 1 from The Phase Ib IMPACT Trial of Intramuscular Personalized Neoantigen Synthetic Long Peptide Vaccines in Patients with Advanced Melanoma and Renal Cell Carcinoma
2026
·
Nussara Pakvisal
, Piriya Wongkongkathep
, et al.
Supplementary Data 4 from The Phase Ib IMPACT Trial of Intramuscular Personalized Neoantigen Synthetic Long Peptide Vaccines in Patients with Advanced Melanoma and Renal Cell Carcinoma
2026
·
Nussara Pakvisal
, Piriya Wongkongkathep
, et al.
Supplementary Data 3 from The Phase Ib IMPACT Trial of Intramuscular Personalized Neoantigen Synthetic Long Peptide Vaccines in Patients with Advanced Melanoma and Renal Cell Carcinoma
2026
·
Nussara Pakvisal
, Piriya Wongkongkathep
, et al.
Show more works
View as search
Works count:
9
Citation count:
14
H-index:
2
I10-index:
1
Year
Topic
Type